Adenoviral vector of serotype 5 modified to contain a chimeric sequence consisting of a minimal urokinase-type plasminogen activator receptor promoter preceded by three Notch-responsive elements, and coated with oligopeptide end-modified poly (beta-amino) esters | |
---|---|
Trade Name | |
Orphan Indication | Pancreatic Cancer |
EU Market Approval | EU |
EU Designation Date | 2017-10-16 00:00:00 |
Sponsor | Sagetis Biotech, S.L. |